Patent Assignment
Reel/Frame 046640/0764
Merger and Change of Name
Recorded: 2018-07-27
Pages: 4
Assignors
PROTIVA BIOTHERAPEUTICS INC.
Executed: 2018-01-01
ARBUTUS BIOPHARMA CORPORATION
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties
(50)
Lipid Containing Formulations
Targeting Lipids
Application:
12/328,669 →
Publication:
US 2009/0247608
Methods of Delivering Oligonucleotides to Immune Cells
Application:
12/774,330 →
Publication:
US 2010/0285112
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
12/811,503 →
Publication:
US 2011/0097720
Liver Screening Method
Application:
12/811,511 →
Publication:
US 2011/0045473
Lipid Formulation
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Amino Lipid Based Improved Lipid Formulation
Application:
12/989,051 →
Novel Lipids and Compositions for the Delivery of Therapeutics
Novel Lipids and Compositions for the Delivery of Therapeutics
Novel Lipids and Compositions for the Delivery of Therapeutics
Lipids and Compositions for the Delivery of Therapeutics
Lipid Formulation
Application:
13/147,189 →
Publication:
US 2012/0101148
Lipid Containing Formulations
Novel Lipids and Compositions for the Delivery of Therapeutics
Application:
13/211,150 →
Publication:
US 2012/0095075
Lipid Compositions
Lipid Formulation
Methods For Increasing Efficacy of Lipid Formulated siRNA
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
13/460,963 →
Publication:
US 2012/0225434
Compositions for Nucleic Acid Delivery
Methods and Compositions for Delivery of Nucleic Acids
Application:
13/516,335 →
Publication:
US 2013/0017223
Methods and Compositions for Delivery of Active Agents
Application:
13/813,122 →
Publication:
US 2013/0323269
Site Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Screening Method for Selected Amino Lipid-Containing Compositions
Application:
14/059,307 →
Publication:
US 2014/0295449
Targeting Lipids
Lipid Containing Formulations
Application:
14/149,496 →
Publication:
US 2014/0121393
Lipid Formulations
Lipid Compositions
Novel Lipids and Compositions for the Delivery of Therapeutics
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
Novel Lipids and Compositions for the Delivery of Therapeutics
Screening Method for Selected Amino-Lipid-Containing Compositions
Application:
14/928,234 →
Publication:
US 2016/0274089
Novel Lipids and Compositions for the Delivery of Therapeutics
Methods and Compositions for Delivery of Active Agents
Application:
15/010,747 →
Publication:
US 2016/0250354
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Methods and Compositions for Delivery of Nucleic Acids
Application:
15/152,216 →
Publication:
US 2016/0317676
Lipid Formulation
Application:
15/187,633 →
Publication:
US 2017/0143631
Novel Lipids and Compositions for the Delivery of Therapeutics
Application:
15/474,911 →
Publication:
US 2018/0064807
Lipid Containing Formulations
Application:
15/492,898 →
Publication:
US 2018/0065918
Lipid Compositions
Compositions for Nucleic Acid Delivery
Application:
15/596,845 →
Publication:
US 2018/0369384
Novel Lipids and Compositions for the Delivery of Therapeutics
Novel Lipids and Compositions for the Delivery of Therapeutics
Novel Lipids and Compositions for the Delivery of Therapeutics
Screening Method for Selected Amino-Lipid-Containing Compositions
Application:
15/693,902 →
Publication:
US 2018/0209963
Targeting Lipids
Application:
15/729,236 →
Publication:
US 2019/0099493
Methods and Compositions for Delivery of Active Agents
Application:
15/788,575 →
Publication:
US 2018/0221510
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Application:
15/837,785 →
Publication:
US 2018/0221494
Methods of Delivering Oligonucleotides to Immune Cells
Application:
15/900,618 →
Publication:
US 2018/0369271
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
Application:
16/036,550 →
Publication:
US 2019/0153443
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 1, 2012
From: FITZGERALD, KEVIN; FRANK-KAMENETSKY, MARIA; AKINC, AKIN; MAIER, MARTIN A.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 028139/0261 →
Assignment of Assignor's Interest
Aug 21, 2012
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G; JAYARAMAN, MUTHUSAMY; BUTLER, DAVID
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 028821/0438 →
Assignment of Assignor's Interest
Jan 23, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 029676/0651 →
Assignment of Assignor's Interest
Jun 28, 2013
From: CHEN, JIANXIN; ANSELL, STEVEN; AKINC, AKIN; DORKIN, JOSEPH ROBERT
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 030706/0747 →
Assignment of Assignor's Interest
Jul 10, 2013
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; AKINC, AKIN; NARAYANANNAIR, JAYAPRAKASH K.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 030769/0316 →
Assignment of Assignor's Interest
Sep 10, 2013
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; JAYARAMAN, MUTHUSAMY; BUTLER, DAVID
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 031177/0425 →
Assignment of Assignor's Interest
Sep 10, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 031177/0516 →
Change of Name
May 19, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 038646/0652 →
Change of Name
Oct 27, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 040154/0419 →
Change of Name
Nov 4, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 040232/0162 →
Change of Name
Nov 4, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 040232/0183 →
Change of Name
Dec 5, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 040531/0005 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0512 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0507 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0522 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0448 →
Change of Name
Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0450 →
Change of Name
Apr 24, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 042132/0518 →
Change of Name
Jun 23, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 042802/0375 →
Change of Name
Sep 7, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 043526/0977 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →